Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRAVOPROST
- Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular Hypertension
- Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
- Travoprost Intraocular Implant in Conjunction With Cataract Surgery
- A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
- Intraocular Pressure Reduction Efficacy of Rhopressa and Lumigan in Normal Tension Glaucoma
- Study of Exchange of Travoprost Intraocular Implant
- Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of Vitiligo
- CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension
- A Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert
- Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
- Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
- Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
- Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT
- Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive Agents
- Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
- Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution
- Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
- Stop Retinal Ganglion Cell Dysfunction Study
- Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma
- Phase 2b Study Evaluating Safety and Efficacy of OTX-TP Compared to Timolol Drops in the Treatment of Subjects With Open Angle Glaucoma or Ocular Hypertension
- 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
- Effect of NSAID on Travoprost-induced Conjunctival Hyperemia and IOP Reduction in Normal Eyes
- Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular Pressure
- Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
- Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure
- Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
- Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
- An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
- Multi-Arm Feasibility Study Evaluating OTX-TP Compared to Timolol in Treatment of Subjects With Open Angle Glaucoma
- A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days
- Travoprost/Timolol vs Latanoprost/Timolol Fixed Combination Therapy
- Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
- Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia
- An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
- Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
- 24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension
- Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
- Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
- Bimatoprost/Timolol Versus Travoprost/Timolol
- Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
- Efficacy of Changing to TRAVATAN® From Prior Therapy
- Travacom Post Marketing Surveillance Study
- Efficacy of Changing to TRAVATAN® From Prior Therapy
- Continuous Intraocular Pressure (IOP) Measurement and Ability to Detect Treatment Effect
- AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
- Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)
- Travoprost 3-Month Safety and Efficacy Study
- Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
- Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost
- Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or Travoprost
- Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma
- Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on Timolol
- Efficacy of Changing to DUOTRAV® From Prior Therapy
- Effects of Anti-Glaucoma Medications on the Ocular Surface
- Divided Dose of TRAVATAN®
- Safety and Efficacy of Adding AZARGA® Adjunctive to Prostaglandin Therapy
- Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Safety and Efficacy of Changing to DuoTrav From Prior Therapy
- To Assess the Safety and Efficacy of Travacom in Patients With Uncontrolled Intraocular Pressure
- Travoprost Five Day Posology Study
- Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure Glaucoma
- 24-Hour Intraocular Pressure With Brinzolamide/Timolol Versus Brimonidine/Timolol
- Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
- Travoprost APS Versus Xalatan® in Patient Reported Outcomes and Ocular Surface Health
- Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension
- Efficacy Study of Travoprost APS Versus TRAVATAN
- Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
- Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative
- Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
- 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT
- Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
- Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
- Safety and Efficacy of Travoprost/Timolol BAC-free
- Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
- Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
- 24-hr IOP With Travoprost/Timolol Compared With Latanoprost/Timolol in XFG
- Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG)
- Effects of Travatan Z and Xalatan on Ocular Surface Health
- The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
- Glaucoma Adherence Study, Spain
- Glaucoma Adherence Study
- Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs
- A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
- IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTrav
- Adherence Assessment With Travalert Dosing Aid
- A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
- Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
- Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
- 24-hour Intraocular Pressure Control With Travoprost/Timolol Fixed Combination Versus Travoprost
- Effects of Travoprost on Neovascular Glaucoma
- Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
- Visual Function Changes After Intraocular Pressure Reduction
- IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
- Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension
- Bimatoprost Monotherapy vs. Dual Therapy With Travoprost and Timolol in Patients With Glaucoma and Ocular Hypertension
- Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%
- 24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination
- Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients
- Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
- Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
- A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma
- A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Clinical trials list
click for details